All In Biotech

Drug Trial Radar · NCT00242047

Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth

Last checked: Nov 19, 2026Latest source record: Oct 19, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 12,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

12,000

Actual

Start

Mar 2001

Primary completion

Not stated

Study completion Aug 2006

Sponsor

Lead sponsor
University of Cape TownAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Aeras; Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan.
First posted
Oct 19, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 0 years, up to 24 hours
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

An open label, randomized, controlled, equivalency trial to compare the efficacy of the percutaneous route of administration with the intradermal route of administration of Japanese (Tokyo) 172 BCG, in the prevention of tuberculosis during the first two years of life.

Conditions

  • Tuberculosis

Interventions

  • Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).Biological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevention of tuberculosis with bacteriological or histological confirmation, or meeting strict clinical criteria,in the first 2 years of life.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town.

    Cape Town, Western Cape, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.